GLP-1s

GLP-1s

GLP-1 Market Winners and Losers Summary

  • GLP-1 Drugs drive significant shifts in global food sector
  • As users prioritize nutrient density, functional ingredients are on the rise.
  • Many consumers find fatty and sugary food less appealing
  • Innovative companies launch protein-rich portions aligned with GLP-1 ranges
  • GLP-1 decreases reward and motivation responses, resulting in a drop in alcohol consumption

GLP-1-based weight loss drugs transformed the food industry in just over a single year. Where they used to be restricted only to treating diabetes, around 12% (according some estimates) of US citizens now use the drugs.

There are always winners and losers in any revolution. GLP-1 follows the same pattern. Markets have provided unprecedented opportunities to some sectors of the food industry, but also posed a significant threat for other.

Winners: Functional ingredients

GLP-1s are primarily used to increase satiety (also known as feeling full). The drugs cause people to consume smaller amounts of food.

GLP-1-users still have to consume the recommended daily intake of nutrients. Foods that are nutrient dense and portion controlled appeal to people.

It is therefore more crucial than ever to use ingredients like protein and fiber in large quantities, as they provide GLP-1 patients with all the nutrition that they require.

Read also: Will GLP-1s be big in Europe by 2026?

Several ingredients were in high demand. One of the main factors driving the global shortage is the prescription of whey by GLP-1-users.

GLP-1 may even benefit electrolyte beverages. Rapid hydration becomes more crucial for GLP-1 users, who tend to drink less fluids. Drinks containing electrolytes provide GLP-1 patients with the much needed hydration boost.

Although not all manufacturers view GLP-1s in a positive light, they see the GLP-1 boom as a chance to develop nutritionally dense foods.

Foods that make you fat and sugary

GLP-1s do not just affect the quantity of food that people want to consume, they can also alter the types of foods consumed.

GLP-1-users often report a lower desire for salty, fatty or starchy foods.

While some studies suggest that GLP-1 users are more likely to be attracted by sweeter foods and drinks, other evidence suggests that the purchase of sugary beverages has fallen around 7%.

Tate & Lyle, an ingredients company, has conducted a recent study that confirms the fact. It found that GLP-1-users dislike large snacks with high fat and sugar content.

GLP-1 has been shown to influence the taste of certain foods and, therefore, what people desire. Food companies should be aware that, while it is not an exact science because all people are different and there’s no one size fits all approach to food consumption, GLP-1 users may change their taste preferences.

(Image: Getty Images/Image Source/Diana Miller) Some foods are less attractive to the consumer once on GLP-1s. (Image: Getty Images/Image Source/Diana Miller)

Winners of the Companion Product Innovation Award

Although GLP-1 has been adopted slowly, key players in the industry have now taken advantage of the opportunity and released new products or expanded existing lines.

Nestle’s nutrient dense Vital Pursuit was the first product to target GLP-1 users. It was a ‘portion-aligned product’, which meant it was smaller, and also high in ingredients like protein, fiber and calcium.

Conagra Brands, a US company, has labeled many of their ‘Healthy Choices’ frozen meals GLP-1-friendly.

Other companies have also embraced the trend. Morrisons, a UK-based supermarket chain, recently launched a range of GLP-1-friendly meals. This range includes high-protein cheeses, ice creams and pastas.

Protein is more important to GLP-1-users than ever before, even though the trend of consuming protein in excess is expected to decrease.

Some products provide a high level of nutrients and are intended for those already taking GLP-1s. Others are focused more on providing satiety via food, as an alternative drug.

These products are still relatively new on the market. Their long-term viability is therefore not guaranteed. GLP-1s are a niche market that has already prompted significant innovation and has a great deal of potential. The analytics firm Future Market Insights forecast that the GLP-1 nutrition support market will grow by 12.2% CAGR between 2025-2035.

Alcohol is a Loser

Alcohol consumption may also suffer from GLP-1s, even though food is the first thing on consumers’ mind.

Research suggests that GLP-1-users often reduce their alcohol consumption over time.

The study found that excessive drinkers are the ones most likely to decrease their overall consumption.

In fact, the statistics confirm this. GLP-1 drinkers are significantly reducing their consumption, according to Morgan Stanley research. Around a quarter have completely stopped drinking.

GLP-1-users are less likely to drink alcohol (Image Getty Images/Luis Alvarez)

A second study suggests that GLP-1 medications not only reduce the consumer’s motivation to drink alcohol, but also potentially decrease alcohol reward.

GLP-1 medications are only just beginning. They have already had a significant impact on the food and drink industry, but they are not slowing down. Many sectors are at risk of losing out. However, those that appeal to GLP-1 users’ different needs could see a boom.

Would you like to learn more about GLP-1s and their impact on F&B products?

Positive Nutrition is a broadcast series that highlights the technologies and innovations at the heart of the development of healthier food and drinks.

We will be holding a workshop on 5th February 2026 titled Global GLP-1 Disruption.

Weight loss jabs have taken the world by storm. They are changing everything, from consumer behavior to product innovations. The impact of weight-loss jabs is felt in all regions and categories. However, the effects in some sectors are not mirrored by others. We examine the impact of disruption on soft drinks, alcohol, snacks and confectionery.

Register now for free.

View Article Source

Share Article
Facebook
LinkedIn
X
Ascot marketing agency says small businesses can win Black Friday week without cutting prices
Harley Street-trained psychotherapist moves his practice to Poland to treat British expats online
DoorDash to buy Instacart in $17bn deal, its largest takeover to date
Secret Link